Calidi Biotherapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Calidi Biotherapeutics, Inc. has filed 392 SEC EDGAR filings since 17 May 2021

SEC filing history

Showing 1-14 of 14 matching filings.

Per page
25
Current page
1
10-Q File 001-40789

10-Q filing

Filing date
12 Nov 2024
Reporting date
30 Sep 2024
Next action
Verify source filing
10-Q File 001-40789

10-Q filing

Filing date
13 Aug 2024
Reporting date
30 Jun 2024
Next action
Verify source filing
10-Q File 001-40789

10-Q filing

Filing date
14 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
10-Q File 001-40789

10-Q filing

Filing date
14 Nov 2023
Reporting date
30 Sep 2023
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .